Intracerebral infusion of a second-generation ciliary neurotrophic factor reduces neuronal loss in rat striatum following experimental intracerebral hemorrhage
Mr. Del Bigio et al., Intracerebral infusion of a second-generation ciliary neurotrophic factor reduces neuronal loss in rat striatum following experimental intracerebral hemorrhage, J NEUR SCI, 192(1-2), 2001, pp. 53-59
Neuronal and glial cell death in the striatum of a rat model of collagenase
-induced intracerebral hemorrhage begins at 1 day and continues for at leas
t 3 weeks. We hypothesized that administration of a neurotrophic agent woul
d reduce neuronal loss in this experimental model. Because it has been show
n to protect striatal neurons against excitotoxic injury, a second-generati
on ciliary neurotrophic factor (CNTF) (AXOKINE (R)) was administered by con
tinuous intracerebral infusion (2 mug/day) beginning 28 h after hemorrhage
and continuing for 2 weeks. Magnetic resonance imaging showed that the hema
toma size was comparable in control and treated rats prior to treatment. Co
unts of medium-sized striatal neurons within 320 mum of the hematoma 8 week
s after the hemorrhage revealed a slight but statistically significant bene
fit with a 42.5% loss in treated rats compared to 51.7% loss in controls. T
he results suggest that AXOKINE might be protective of striatal neurons in
the vicinity of a hemorrhagic lesion. (C) 2001 Elsevier Science B.V. All ri
ghts reserved.